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**Abstract**

The serotonin and neurotrophic factor hypotheses of depression are well known. The discovery of brain fibroblast-growth factor receptor 1 (FGFR1)-5 hydroxytryptamine receptor 1A (5-HT1A) heteroreceptor complexes, and their enhancement of neuroplasticity, offers an integration of these hypotheses at molecular level. They were first described in the hippocampus and later in midbrain 5-HT neurons, where these heterocomplexes are enriched in 5-HT1A autoreceptors. Combined FGF-2 and 5-HT1A agonist treatment increased formation of these heterocomplexes and the facilitatory allosteric receptor-receptor interactions within them led to an enhancement of FGFR1 signaling and was associated with development of antidepressant effects. The learning objective is to give an increased understanding of the FGFR1-5-HT1A heteroreceptor complexes in depression as well as of their pharmacology, allosteric receptor-receptor interactions and dynamics of trafficking and balance. We will discuss these findings with respect to a theory of motifs critically involved in these interactions. The aim is also to give an increased understanding of the FGFR1-5-HT1A heteroreceptor complex as a new promising target for antidepressant drugs including combined treatment with FGF2 and 5-HT1A agonists in major depression.
